+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
Type 1 Diabetes (Juvenile Diabetes) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Type 1 Diabetes (Juvenile Diabetes) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 1657 Pages
  • Global
From
Erythrodermic Psoriasis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Erythrodermic Psoriasis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 52 Pages
  • Global
From
Acute Decompensated Heart Failure - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Acute Decompensated Heart Failure - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 191 Pages
  • Global
From
Pulmonary Fibrosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Pulmonary Fibrosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 624 Pages
  • Global
From
Meningitis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Meningitis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 398 Pages
  • Global
From
Actinic (Solar) Keratosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Actinic (Solar) Keratosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 289 Pages
  • Global
From
Alopecia Areata: Opportunity Assessment and Forecast to 2033 - Product Thumbnail Image

Alopecia Areata: Opportunity Assessment and Forecast to 2033

  • Report
  • March 2025
  • 81 Pages
  • Global
From
From
Fragile X Syndrome - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Fragile X Syndrome - Global Clinical Trials Review, 2025

  • Clinical Trials
  • February 2025
  • 104 Pages
  • Global
From
Diabetic Nephropathy - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Diabetic Nephropathy - Global Clinical Trials Review, 2025

  • Clinical Trials
  • January 2025
  • 615 Pages
  • Global
From
Friedreich Ataxia - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Friedreich Ataxia - Global Clinical Trials Review, 2025

  • Clinical Trials
  • January 2025
  • 108 Pages
  • Global
From
Alzheimer's Disease: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Alzheimer's Disease: 68-Market Analysis and Sales Forecast

  • Report
  • January 2025
  • 19 Pages
  • Global
From
From
From
Obstructive Sleep Apnea - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Obstructive Sleep Apnea - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 339 Pages
  • Global
From
Tourette Syndrome - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Tourette Syndrome - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 138 Pages
  • Global
From
Febrile Neutropenia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Febrile Neutropenia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 201 Pages
  • Global
From
Type 1 Diabetes: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Type 1 Diabetes: Seven-Market Drug Forecast and Market Analysis

  • Report
  • December 2024
  • 144 Pages
  • Global
From
Alzheimer's Disease (AD): Epidemiology Forecast to 2033 - Product Thumbnail Image

Alzheimer's Disease (AD): Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 49 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more